Publications by authors named "Gerd Assmann"

Claim this Profile
E
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Lisa Pennells, Stephen Kaptoge, Angela Wood, Mike Sweeting, Xiaohui Zhao, Gerd Assmann

Eur Heart J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Risk Factors Associated With Venous Thromboembolism.
John Gregson, Stephen Kaptoge, Thomas Bolton, Lisa Pennells, Peter Willeit, Gerd Assmann

JAMA Cardiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.
Angela M Wood, Stephen Kaptoge, Adam S Butterworth, Peter Willeit, Samantha Warnakula, Gerd Assmann

Lancet· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.
Ellie Paige, Jessica Barrett, Lisa Pennells, Michael Sweeting, Peter Willeit, Gerd Assmann

Am J Epidemiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk.
Dirk Müller-Wieland, Gerd Assmann, Rafael Carmena, Jean Davignon, Arnold von Eckardstein

Eur J Prev Cardiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Cardiometabolic Multimorbidity With Mortality.

JAMA· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart, Jean Davignon, Michel P Hermans, Khalid Al-Rubeaan, Pierre Amarenco, Gerd Assmann

Cardiovasc Diabetol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein, fibrinogen, and cardiovascular disease prediction.

N Engl J Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-related markers and cardiovascular disease prediction.

JAMA· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care.
Kurt Bestehorn, Wenefrieda Smolka, David Pittrow, Helmut Schulte, Gerd Assmann

Curr Med Res Opin· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of human MAPCs for stem cell transplantation and cardiac regeneration after myocardial infarction in SCID mice.
Ilias Dimomeletis, Elisabeth Deindl, Marc Zaruba, Michael Groebner, Stefan Zahler, Gerd Assmann

Exp Hematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-LDL-related dyslipidaemia and coronary risk: a case-control study.
Gerd Assmann, Paul Cullen, Helmut Schulte

Diab Vasc Dis Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Jean-Charles Fruchart, Frank M Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown

Diab Vasc Dis Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
Jean-Charles Fruchart, Frank Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown

Am J Cardiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
Jörg Stypmann, Aurelien Schubert, Henryk Welp, Helmut Schulte, Gerd Assmann

Clin Cardiol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production.
Markus Tölle, Alicja Pawlak, Miriam Schuchardt, Akira Kawamura, Uwe J Tietge, Gerd Assmann

Arterioscler Thromb Vasc Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol.
Odilo Mueller, Elaine Chang, David Deng, Torsten Franz, Debra Jing, Gerd Assmann

Clin Chem Lab Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
Gerd Assmann, Frank Kannenberg, Dena R Ramey, Thomas A Musliner, Stephen W Gutkin

Curr Med Res Opin· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes, diet and public health.
Udo Seedorf, Helmut Schulte, Gerd Assmann

Genes Nutr· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of cholesteryl ester storage disease.
Sandro Muntoni, Heiko Wiebusch, Marianne Jansen-Rust, Stephan Rust, Udo Seedorf, Gerd Assmann

Arterioscler Thromb Vasc Biol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells.
Akira Kawamura, Daniel Baitsch, Ralph Telgmann, Renata Feuerborn, Gabriele Weissen-Plenz, Gerd Assmann

Arterioscler Thromb Vasc Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol.
Thomas Engel, Frank Kannenberg, Manfred Fobker, Jerzy-Roch Nofer, Guenther Bode, Gerd Assmann

FEBS Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study.
Gerd Assmann, Paul Cullen, Frank Kannenberg, Helmut Schulte

Eur J Cardiovasc Prev Rehabil· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
Anette E Buyken, Arnold von Eckardstein, Helmut Schulte, Paul Cullen, Gerd Assmann

Eur J Cardiovasc Prev Rehabil· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
Gerd Assmann, Rudy Guerra, Garrett Fox, Paul Cullen, Helmut Schulte

Am J Cardiol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis